Haleon (HLN) Shares Outstanding (2021 - 2026)
Haleon's (HLN) quarterly Shares Outstanding (Entity) came in at $4.3 billion in Q2 2026, down 0.75% on a QoQ basis from $4.4 billion in Q4 2025.
Haleon (HLN) Shares Outstanding (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Shares Outstanding (Entity) data on file, last reported at $4.3 billion in Q2 2026.
- Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $4.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.3 billion (changed N/A YoY) and the FY2025 annual result came in at $4.4 billion, down 1.64% from the prior year.
- Shares Outstanding (Entity) declined to $4.3 billion in Q2 2026, from $4.4 billion in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $384.8 billion in Q2 2023 to a low of $12389.0 in Q3 2022.
- A 5-year average of $45.2 billion and a median of $4.4 billion in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 1883029.39% — and 2024, when it sank 98.84%.
- Tracing HLN's Shares Outstanding (Entity) over 5 years: stood at $20.4 million in 2022, then soared by 21944.01% to $4.5 billion in 2023, then decreased by 1.09% to $4.5 billion in 2024, then dropped by 1.64% to $4.4 billion in 2025, then decreased by 0.75% to $4.3 billion in 2026.
- The last three Shares Outstanding (Entity) figures came in at $4.3 billion (Q2 2026), $4.4 billion (Q4 2025), and $4.5 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 167.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.92 Bn |
| Dec 31, 2025 | 8.98 Bn |
| Dec 31, 2024 | 9.13 Bn |
| Jun 30, 2024 | 9.18 Bn |
| Dec 31, 2023 | 9.23 Bn |
| Jun 30, 2023 | 9.23 Bn |
| May 3, 2023 | 9.24 Bn |
| Dec 31, 2022 | 9.24 Bn |
| Sep 20, 2022 | 5.60 Mn |
| Jun 30, 2022 | 9.24 Bn |
| Dec 31, 2021 | 9.24 Bn |